Harbin Pharmaceutical Group Co (SHSE:600664) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co 5-Year EBITDA Growth Rate?

Harbin Pharmaceutical Group Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.10.

During the past 12 months, Harbin Pharmaceutical Group Co's average EBITDA Per Share Growth Rate was -1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Harbin Pharmaceutical Group Co was 25.90% per year. The lowest was -27.20% per year. And the median was 7.05% per year.

Competitive Comparison of Harbin Pharmaceutical Group Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harbin Pharmaceutical Group Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's 5-Year EBITDA Growth Rate falls into.

Harbin Pharmaceutical Group Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Harbin Pharmaceutical Group Co (SHSE:600664) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Harbin Pharmaceutical Group Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018

Website

http://www.hayao.com

Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.

Executives

Lin Guo Ren	senior management
Wang Hai Sheng	senior management
Liu Bo	senior management
Meng Xiao Dong	senior management
Xu Hai Ying	Directors, senior managers
Liang Chen	senior management
Wang Peng Hao	senior management
Xiao Qiang	senior management
Wei Shuang Ying	senior management
Zhou Xing	senior management
Bian Ke	Supervisors
Sha Mei	senior management
Jian Shi Hui Zhu Xi	Supervisors
Wang Zhi Fu	Supervisors
Jiang Lu	Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines